[Analgesic effect of Rowapraxin (BR-18) in urological diseases].
D000284:Administration, Oral; D000328:Adult; D000700:Analgesics / Q000627:therapeutic use*; D003556:Cystitis / Q000188:drug therapy; D004149:Dioxoles / Q000627:therapeutic use*; D005260:Female; D006470:Hemorrhage / Q000188:drug therapy; D006801:Humans; D006869:Hydronephrosis / Q000188:drug therapy; D007669:Kidney Calculi / Q000188:drug therapy; D008297:Male; D008875:Middle Aged; D010880:Piperidines / Q000627:therapeutic use; D011472:Prostatitis / Q000188:drug therapy; D014401:Tuberculosis, Urogenital / Q000188:drug therapy; D014515:Ureteral Diseases / Q000188:drug therapy; D014570:Urologic Diseases / Q000188:drug therapy*
D000700:Analgesics; D004149:Dioxoles; D010880:Piperidines